Zhang, Xi

Engineering CAR-T cells

Zhang, C., Liu, J., Zhong, J. F., & Zhang, X. (2017) · Biomarker Research

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 578

Strategies to enhance CAR-T persistence

Liu, Y., An, L., Huang, R., Xiong, J., Yang, H., Wang, X., & Zhang, X. (2022) · Biomarker Research

CAR-T cell therapy researchImmunotherapy and Immune Responses

Cited by 97

Nuclear receptors as therapeutic targets in liver disease: are we there yet?

Rudraiah, S., Zhang, X., & Wang, L. (2016) · Annual Review of Pharmacology and Toxicology

Nuclear Receptors and SignalingPeroxisome Proliferator-Activated Receptors

Cited by 87

Preparation and evaluation of antigen/N-trimethylaminoethylmethacrylate chitosan conjugates for nasal immunization

Liu, Q., Zhang, C., Zheng, X., Shao, X., Zhang, X., Zhang, Q., & Jiang, X. (2014) · Vaccine

Advanced Drug Delivery SystemsImmunotherapy and Immune Responses

Cited by 22

CD19-directed fast CART therapy for relapsed/refractory acute lymphoblastic leukemia: from bench to bedside

Zhang, C., He, J., Liu, L., Wang, J., Wang, S., Liu, L., Gao, L., Gao, L., Liu, Y., Kong, P., et al. (2019) · Blood

CAR-T cell therapy researchAcute Lymphoblastic Leukemia research

Cited by 17